These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1836496)
21. Some morphometric observations on the brains of patients with Down's syndrome: their relationship to age and dementia. Mann DM; Royston MC; Ravindra CR J Neurol Sci; 1990 Nov; 99(2-3):153-64. PubMed ID: 2150858 [TBL] [Abstract][Full Text] [Related]
22. Nature of mental retardation and dementia in Down syndrome: study with PET, CT, and neuropsychology. Schapiro MB; Haxby JV; Grady CL Neurobiol Aging; 1992; 13(6):723-34. PubMed ID: 1491738 [TBL] [Abstract][Full Text] [Related]
23. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Mann DM; Jones D; Prinja D; Purkiss MS Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007 [TBL] [Abstract][Full Text] [Related]
24. A study of digestive absorption in four cases of Down's syndrome. Down's syndrome, malnutrition, malabsorption, and Alzheimer's disease. Abalan F; Jouan A; Weerts MT; Solles C; Brus J; Sauneron MF Med Hypotheses; 1990 Jan; 31(1):35-8. PubMed ID: 2138242 [TBL] [Abstract][Full Text] [Related]
25. Dementia and mortality in persons with Down's syndrome. Coppus A; Evenhuis H; Verberne GJ; Visser F; van Gool P; Eikelenboom P; van Duijin C J Intellect Disabil Res; 2006 Oct; 50(Pt 10):768-77. PubMed ID: 16961706 [TBL] [Abstract][Full Text] [Related]
26. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029 [TBL] [Abstract][Full Text] [Related]
27. Levodopa-responsive parkinsonism in a patient with Down's syndrome. Singer C; Sanchez-Ramos J; Weiner WJ Eur Neurol; 1990; 30(5):247-8. PubMed ID: 2148520 [TBL] [Abstract][Full Text] [Related]
28. Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome. Naudé PJ; Dekker AD; Coppus AM; Vermeiren Y; Eisel UL; van Duijn CM; Van Dam D; De Deyn PP J Alzheimers Dis; 2015; 45(3):733-43. PubMed ID: 25613101 [TBL] [Abstract][Full Text] [Related]
29. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261 [TBL] [Abstract][Full Text] [Related]
30. Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down's syndrome, AIDS and Alzheimer's disease? Regland B; Gottfries CG Med Hypotheses; 1992 May; 38(1):11-9. PubMed ID: 1535413 [TBL] [Abstract][Full Text] [Related]
31. [Adaptation and validation of CAMDEX-DS (Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and others with intellectual disabilities) in Spanish population with intellectual disabilities]. Esteba-Castillo S; Dalmau-Bueno A; Ribas-Vidal N; Vilà-Alsina M; Novell-Alsina R; García-Alba J Rev Neurol; 2013 Oct; 57(8):337-46. PubMed ID: 24081888 [TBL] [Abstract][Full Text] [Related]
32. Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different ages. Schapiro MB; Luxenberg JS; Kaye JA; Haxby JV; Friedland RP; Rapoport SI Neurology; 1989 Oct; 39(10):1349-53. PubMed ID: 2529453 [TBL] [Abstract][Full Text] [Related]
33. [Correlative study of the brain CT and clinical features of patients with Down's syndrome in three clinical stages of Alzheimer type dementia]. Maruyama K; Ikeda S; Yanagisawa N Rinsho Shinkeigaku; 1995 Jul; 35(7):775-80. PubMed ID: 8777802 [TBL] [Abstract][Full Text] [Related]
34. Precocious aging and dementia in patients with Down's syndrome. Wisniewski K; Howe J; Williams DG; Wisniewski HM Biol Psychiatry; 1978 Oct; 13(5):619-27. PubMed ID: 153156 [TBL] [Abstract][Full Text] [Related]
35. Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults. Haxby JV J Ment Defic Res; 1989 Jun; 33 ( Pt 3)():193-210. PubMed ID: 2526879 [TBL] [Abstract][Full Text] [Related]
37. Fibroblasts of patients affected by Down's syndrome oversecrete amyloid precursor protein and are hyporesponsive to protein kinase C stimulation. Govoni S; Bergamaschi S; Gasparini L; Quaglia C; Racchi M; Cattaneo E; Binetti G; Bianchetti A; Giovetti F; Battaini F; Trabuechi M Neurology; 1996 Oct; 47(4):1069-75. PubMed ID: 8857747 [TBL] [Abstract][Full Text] [Related]
38. Down's syndrome and Parkinson's disease. Hestnes A; Daniel SE; Lees AJ; Brun A J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):289. PubMed ID: 9069490 [No Abstract] [Full Text] [Related]
39. Presenilin 1 and alpha-1-antichymotrypsin polymorphisms in Down syndrome: no effect on the presence of dementia. Tyrrell J; Cosgrave M; McPherson J; Hawi Z; Trulock V; Calvert J; Lawlor B; Gill M Am J Med Genet; 1999 Dec; 88(6):616-20. PubMed ID: 10581479 [TBL] [Abstract][Full Text] [Related]